Methods: Case definitions of severe malaria were developed from a

Methods: Case definitions of severe malaria were developed from a literature review and a consensus meeting of expert consultants and the RTS, S Clinical Trial Partnership Committee, in collaboration with the World Health Organization and the Malaria Clinical Trials Alliance. The same groups, with input from an Independent Data Monitoring Committee, developed and implemented a programme for standardized data collection. The case definitions developed reflect the typical ATM/ATR mutation presentations of

severe malaria in African hospitals. Markers of disease severity were chosen on the basis of their association with poor outcome, occurrence in a significant proportion of cases and on an ability to standardize their measurement across research centres. For the primary case definition, one or more clinical and/or laboratory markers of disease severity have to be present, four major co-morbidities

(pneumonia, meningitis, bacteraemia or gastroenteritis with severe dehydration) are excluded, and a Plasmodium falciparum parasite density threshold is introduced, in order to maximize the specificity of the case definition. Secondary case definitions allow inclusion of co-morbidities and/or allow for the presence of parasitaemia at any density. The programmatic implementation of standardized case assessment included a clinical algorithm for evaluating seriously sick children, improvements to care delivery and a robust training and evaluation programme for clinicians.

Conclusions: The case definition developed for the pivotal phase III EPZ004777 concentration RTS, S vaccine study is consistent with WHO recommendations, is locally applicable and appropriately balances sensitivity and specificity in the diagnosis of severe malaria. Processes set up to standardize severe malaria data collection will allow robust assessment of the efficacy of the RTS, S vaccine Citarinostat order against severe malaria, strengthen local capacity and benefit patient care for subjects in the trial.”
“Polymer-Au nanocomposite films were prepared by co-sputtering from two independent magnetron sources. By sputtering from gold and polytetrafluoroethylene (PTFE)

magnetrons, we prepared homogenous composite films using a rotatable sample holder. The microstructure of the nanocomposites was studied by transmission electron microscopy (TEM). The resistivity drops from 107 to 10-3 Ohm cm over a narrow range of metal content. The thin composite films show a strong optical absorption in the visible region due to surface plasmon resonances. The optical absorption has a strong dependence on the metal content, showing a red shift of the absorption peak from 550 nm to more than 700 nm with increasing gold content. (c) 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2012″
“Background: Sarcopenia seems to be attributed to a blunted muscle protein synthetic response to food intake and exercise.

Comments are closed.